Dallas, TX 4/8/2008 4:55:01 AM
News / Finance

OTCPicks.com Stocks to Watch for Tuesday, April 8th PSTI, EXPT, FNLH, RBRM, TDLP, EESO

OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets.  In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit http://www.otcpicks.com/ today to join this growing community.

 

Our Stocks to Watch tomorrow include Pluristem Therapeutics Inc. (NASDAQ: PSTI), Expert Group Inc. (OTC: EXPT), Fineline Holdings Inc. (OTC: FNLH), ReBuilder Medical Technologies Inc. (OTC: RBRM), Transdel Pharmaceuticals Inc. (OTCBB: TDLP) and Enzyme Environmental Solutions Inc. (OTC: EESO).

 

For the complete newsletter please visit: http://www.otcpicks.com/stocks-to-watch/index.php

 

For more in-depth coverage of small cap stocks visit http://www.otcpicks.com/

 

PLURISTEM THERAPEUTICS (NASDAQ: PSTI)

"Up 107.90% on Monday"

 

Detailed Quote: http://www.otcpicks.com/quotes/PSTI.php

 

Pluristem Therapeutics, Inc. engages in the research and development of the mesenchymal and stem cell production technology, and the commercialization of cell therapy products. The company is developing a platform designed to create a functional stem cell production system that can treat severe blood, cardiovascular, autoimmune, and other disorders. It develops PluriX Bioreactor System, which is designed to be a system of stromal cell cultures and substrates that creates an artificial physiological environment where mesenchymal stem cells can grow and reproduce outside of the human body without any use of exogenous biologics or pharmacologicals. The company's principal product, PLX-I is intended to resolve the shortfall of matched tissue for bone marrow transplantation by improving the engraftment of hematopoietic stem cells contained umbilical cord blood. Pluristem's products are derived from mesenchymal stem cells obtained from the placenta and expanded in its proprietary PluriX 3D bioreactor that imitates the natural microstructure of bone marrow and does not require supplemental growth factors, cytokines, or other exogenous materials. The company was founded in 2001 as A.I. Software, Inc. and changed its name to Pluristem Life Systems, Inc. in 2003. Further, it changed its name to Pluristem Therapeutics, Inc. in November 2007. Pluristem Therapeutics is based in Haifa, Israel.

 

EXPERT GROUP INCORPORATED (OTC: EXPT)

"Up 130.00% on Monday"

 

Detailed Quote: http://www.otcpicks.com/quotes/EXPT.php

 

Expert Group, Inc. is a diversified financial services company which markets a variety of financial products and services through Expert Financing, Expert Group Title Services, Expert Credit Fix USA. Expert is licensed by the department of Financial Regulations and a member of FAMB, and since inception, Expert has originated over $50 million in origination. The Company offers a stock option plan to its loan officers, brokers, title agents, and processors.

 

FINELINE HOLDINGS INCORPORATED (OTC: FNLH)

"Up 65.00% on Monday"

 

Detailed Quote: http://www.otcpicks.com/quotes/FNLH.php

 

Fineline Holdings, Inc. engages in the creation and development of cartoon characters for licensing and merchandising to corporations. The company’s products include cartoons and cartoon groups. It also maintains an e-commerce Internet signature store that sells FineLine branded apparel and products, including designer shirts, women Jersey tops and dresses, and T-shirts. As of September 30, 2004, the company had 147 trademarked and copyrighted cartoons. It markets its products in the United States, Canada, Mexico, Europe, Asia, and South America. The company was formed in 1988 as Fineline Properties, Inc. and changed its name to Fineline Properties.Com, Inc. in 1998. Further, the name was changed to Fineline Holdings, Inc. in January 2005. Fineline Holdings is based in Kent, Ohio.

 

REBUILDER MEDICAL TECHNOLOGIES (OTC: RBRM)

"Up 43.33% on Monday"

 

Detailed Quote: http://www.otcpicks.com/quotes/RBRM.php

 

ReBuilder Medical Technologies, Inc. has been successfully inventing, developing, manufacturing, and distributing medical devices for five years via the internet. The company is now expanding its marketing to reach beyond the internet to include physician's offices and late night TV infomercials. RBRM is about to roll out its new line of personal hygiene products for those who suffer with diabetes as well. The company is also performing R&D on two new devices, one to make veins "pop out" to make it easier for nurses to draw blood samples and another to detect allergies electronically. ReBuilder Medical Technologies is headed by David B. Phillips, Ph.D., who has a successful 30 year history of inventing medical devices that include the first infrared ear thermometer (FirsTemp), the GST System for Breast Cancer Detection, and other medical innovations. Sales for 2007 have doubled each month over the same period in 2006. Current sales volume is at the rate of $3 million annually. ReBuilder Medical Inc. is a multi-disciplinary medical device company specializing in neuropathy, molluscum and diabetes.

 

TRANSDEL PHARMACEUTICALS INCORPORATED (OTCBB: TDLP)

"Up 54.55% on Monday"

 

Detailed Quote: http://www.otcpicks.com/quotes/TDLP.php

 

Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of non-invasive topically delivered medications. The company's lead topical drug candidate, Ketotransdel, utilizes its proprietary Transdel cream formulation to facilitate the passage of ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), through the epidermis and into underlying tissues. Ketotransdel provides an alternative to the oral administration of cyclooxygenase-2 selective NSAIDs (COX-2 inhibitors) and non-selective NSAIDs. It has completed a Phase 1/2 trial for treating soft tissue pain and soreness in a delayed onset muscle soreness model with Ketotransdel. Transdel Pharmaceuticals also investigates other drug candidates and treatments for transdermal delivery using Transdel technology, including anesthetics, human hormone replacement, and anti-nausea medications. The company was founded in 1998 and is headquartered in La Jolla, California.

 

ENZYME ENVIRONMENTAL (OTC: EESO)

"Up 52.94% on Monday"

 

Detailed Quote: http://www.otcpicks.com/quotes/EESO.php

 

Enzyme Consultants Organization (ECO) is a U.S. based manufacturer of industrial and agricultural enzyme products. All manufacturing, testing, and formulating are conducted in its manufacturing plant, located in Fort Wayne, Indiana. ECO strives to become a leader in ecological friendly or “Green Products” targeting the industrial and agricultural markets. It is our goal to have the best performing products on the market in each industry. Developing a growing and satisfied customer base is our number one marketing strategy.

 

About OTCPicks.com

 

OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor.  The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.

 

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

 

Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release.

 

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.